WISN 12 Milwaukee on MSN

The key to cancer care? It may be a healthy gut, according to new research

EDITOR’S NOTE: This story was reported in collaboration with the Global Health Reporting Center with support from the ...

A healthier gut may be key to cancer care

Dubbed “the next frontier of cancer prevention and care,” the microbiome appears to be especially critical when it comes to ...

Veracyte Announces Commercial Launch of the Prosigna Breast Test in the U.S.

Genomic test using whole-transcriptome next-generation sequencing technology will be available to order on June 8. The Prosigna test predicts chemotherapy benefit and quantifies 1 ...
The Manila Times

Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients

Joint partnership leverages Alpha Tau’s highly potent, localized alpha-radiation technology and Tolmar’s commercial ...
India Today on MSN

Cancer Daily Horoscope Today (Jun 21 - Jul 22), June 2, 2026: Colleagues Will Be Supportive, Be Clear in Commercial Transactions

Read Cancer Zodiac Sign Horoscope (Jun 21 - Jul 22) Prediction Today for June 2, 2026: Tasks will be accomplished through ...
India Today on MSN

Financial horoscope today, June 2, 2026: Cancer signs should keep commercial transactions clear, know the status of other signs

Today's Financial Horoscope, June 2, 2026: Your investment efforts will continue to increase. You will receive routine ...

A Key Endometriosis & Breast Cancer Drug Is Being Pulled From Australia: ‘Deeply Concerned’

AstraZeneca will discontinue the Zoladex 3.6mg implant in Australia from November 2026, affecting people with breast cancer ...

Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the top penny stocks to buy in investors’ stock portfolio.
KFGO

British drug-cost watchdog recommends use of AbbVie’s ovarian cancer therapy

The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, Elahere, for patients ...

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it will participate in a virtual fireside chat hosted by ...
heraldsun.com.au

Critical breast cancer, endometriosis drug pulled from Australian shelves

Zoladex (or goserelin) 3.6mg implants will be removed from the Pharmaceutical Benefits Scheme and be unavailable for patients to purchase via a private prescription from November 1, due to a ...